New Study Examines Effect of Air Pollution on Those With Early Stage Lung Cancer

Article

A recent study proved that patients with early stage lung cancer who live in areas with poor air quality have shorter survival spans than those who live where the air quality is better.

It comes as no surprise that breathing in clean air is better for a person than taking in polluted air, but new research proves it has a great impact on patients who have been diagnosed with lung cancer.

Researchers from the Keck School of Medicine at the University of Southern California (USC) found that the median survival of patients with early stage lung cancers who lived in areas with high levels of pollution was approximately three years shorter.

The research is based on data from more than 350,000 patients in the California Cancer Registry who were diagnosed with lung cancer between 1988 and 2009. Researchers looked at patients with localized cancer and patients whose cancers had metastasized.

“There’s a growing number of articles out there that show air pollution is associated with lung cancer incidence and mortality,” says Sandrah Eckel, an assistant professor of preventive medicine at USC.

“Due to the high case fatality rate, it’s actually been pretty hard to disentangle the relationship between air pollution and incidence or air pollution and mortality. We realized this lung cancer registry offered us an interesting opportunity to actually look at the effect of air pollution on survival after diagnosis.”

In those with localized lung cancer living in areas with higher levels of air pollution, the median survival was 2.4 years compared with 5.7 years in patients living in areas with lower levels. In cases in which lung cancer had metastasized, researchers observed shorter survival among patients overall, with little difference between high and low exposures of air pollution.

The pollutants studied in this analysis included nitrogen dioxide (NO2), ozone (O3) and particulate matter (PM10 and PM2.5). Eckel says strong associations were seen both with N02, PM10 and PM2.5. Ozone pollution elicited the smallest change in median survival.

If patients diagnosed with early stage lung cancer are concerned about air quality, Eckel explains that there are some common sense precautions that all people — not just those with lung cancer — can take.

“If you’re planning to exercise, which is really important, maybe take into account what the air quality alert is for that day and if it’s going to be a high pollution day, don’t exercise outside” she says. “Exercise inside or rearrange your schedule to exercise at the time of day when air pollution is lower or in a park that’s not close to a busy roadway. If you’re at home and it’s a hot day out, rather than opening the windows, turn on the air conditioning to keep pollution out.”

Eckel adds that having an air filtration system in your home or using the recirculate setting on your car’s air conditioning system while sitting in heavy traffic would be beneficial to one’s health as well. She also notes that coastal regions tend to have cleaner air.

“One takeaway that I find interesting is that there’s been more and more emphasis on early screening to detect early stage lung cancer, so I think that as there’s more and more screening done we’re going to be detecting more people with early stage lung cancer and these are the people who we found air pollution had the biggest effect in,” Eckel says. “I think that the issue of air pollution for them is really important.”

While this study revealed important findings, Eckel says more studies need to be completed; such as possibility doing an intervention study to study the effect of air filters in homes.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content